BridgeMD
Tests treatment safety and results for Ectopia Lentis
Official title Efficacy of Visual and Perceptual Training on Visual Function for Operative Congenital Ectopia Lentis Children
ClinicalTrials.gov ID: NCT07096622
What this study is testing
- What it's testing
- This is a multi-centre, open-label, parallel-group randomized controlled trial with the following objectives: Firstly, the investigators aim to evaluate the efficacy of web-based visual and perceptual training therapy on visual function in children with postoperative congenital ectopia lentis. Secondly, the investigators target to investigate the in stereoacuity, quality of life scores, and treatment compliance following visual and perceptual training intervention.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 4 to 12
You may be able to join if
- Aged 4-12 years, with no gender restriction;
- Diagnosed with congenital ectopia lentis;
- Underwent bilateral lensectomy combined with IOL scleral fixation, and within 1 month ± 1 week after the second-eye surgery;
- Best-corrected visual acuity (BCVA) of unilateral or bilateral eyes is no worse than 20/200 but below the normal level for the corresponding age: for...
- Written informed consent signed by the patient and their parents or legal guardians.
You likely can't join if
- History of ocular trauma or previous ocular surgery other than the study-related procedure;
- Unable to cooperate with treatment, examinations, and follow-up assessments;
- Complicated with recurrent lens dislocation, severe cataract (dense, axial, opacity diameter \>3 mm and affecting central vision), secondary...
- Presence of diplopia in either eye;
- Known history of neurological disorders (e.g., photosensitive epilepsy);
- Participation in other clinical trials within the postoperative period that may affect the outcomes of the present study;
See the full eligibility criteria
- Aged 4-12 years, with no gender restriction;
- Diagnosed with congenital ectopia lentis;
- Underwent bilateral lensectomy combined with IOL scleral fixation, and within 1 month ± 1 week after the second-eye surgery;
- Best-corrected visual acuity (BCVA) of unilateral or bilateral eyes is no worse than 20/200 but below the normal level for the corresponding age: for 4-year-old children, BCVA ≤ 20/40; for children aged 5 years and...
- Written informed consent signed by the patient and their parents or legal guardians.
- History of ocular trauma or previous ocular surgery other than the study-related procedure;
- Unable to cooperate with treatment, examinations, and follow-up assessments;
- Complicated with recurrent lens dislocation, severe cataract (dense, axial, opacity diameter \>3 mm and affecting central vision), secondary glaucoma, corneal endothelial decompensation, retinal detachment, or other...
- Presence of diplopia in either eye;
- Known history of neurological disorders (e.g., photosensitive epilepsy);
- Participation in other clinical trials within the postoperative period that may affect the outcomes of the present study;
- Use of topical or systemic medications that may cause visual impairment, or other vision therapies other than refractive correction in the past 3 months (e.g., atropine penalization, occlusion therapy, digital therapy...
The study team makes the final eligibility decision.
Where it's taking place
- Guangzhou, Guangdong, China
- Qingyuan, Guangdong, China
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 4 years to 12 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Guangzhou, Guangdong, China; Qingyuan, Guangdong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.